Viewing nowRavista Tablet (Raloxifene Hydrochloride)
Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

MFDS item code 201601006 · Approved 2016.02.23 · Insurance code 653403560
Treatment and prevention of postmenopausal osteoporosis
This medicine is used to treat and prevent osteoporosis in postmenopausal women.
Administer 60 mg orally once daily as Raloxifene Hydrochloride.
This medication may increase the risk of developing blood clots in the bloodstream; therefore, patients at risk of thrombosis should use it with caution. If immobility occurs for an extended period, the medication should be discontinued and may be resumed once the condition improves. It is not recommended for patients with poor liver function as the drug is primarily processed in the liver, and liver function tests should be periodically monitored. It is not suitable for premenopausal women, and pregnant women or those who may become pregnant and nursing mothers should not take this medication. Caution is required in postmenopausal women at high risk of cardiovascular disease, and it should not be used for cardiovascular prevention. The combined use of this drug with estrogen is not recommended as safety has not been established. If uterine bleeding occurs during treatment, consult a healthcare professional immediately, and patients with a history of breast cancer should discuss with their doctor before taking this medication. Additionally, while this medication is used for the treatment of osteoporosis, it should not be administered to males or children. In cases of overdose, leg cramps or dizziness may occur, so caution is advised, and there is no specific antidote. This drug has minimal interactions with other medications, but periodic monitoring of blood clotting tests is required when used in conjunction with certain drugs. When storing, keep it in a secure place out of reach of children and do not transfer to another container. It is advisable to supplement calcium and vitamin D if deficiencies are noted during treatment and to improve smoking and drinking habits. The effect on driving or operating machinery is not known.
Venous thromboembolism, including deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, superficial vein thrombophlebitis, thrombocytopenia, increased blood pressure, stroke, arterial thromboembolism, retinal vein occlusion, and death related to venous thromboembolism.
Vasodilation (flushing), leg cramps, cold symptoms, peripheral edema, nausea, vomiting, abdominal pain, dyspepsia, migraine, rash, breast symptoms (pain, swelling, tenderness), vaginal bleeding, facial edema, heartburn, constipation, itching, palpitations, fever, weakness, sweating, myalgia, insomnia, perineal pain, weight gain, arthritis, rheumatic-like symptoms, pain, fatigue, discomfort, chest pain, skin lesions, anxiety, weight loss, seizures,
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent air from entering and kept at a relatively warm indoor temperature between 15 to 30 degrees Celsius. Storing it this way helps maintain its effectiveness and prevent degradation.
White oval film-coated tablet
28 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRaloxifene Hydrochloride 60mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Alvogen Korea Co., Ltd.

Raloxifene Hydrochloride Monohydrate 62.12mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Huons Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Ilsung IS Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Raloxifene Hydrochloride
Prescription medication
Searle Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.